Letter from Dr. Stephen I. Katz: Maximizing the Value of NIH-funded Clinical Trials
Date: July 27, 2016
Letter from Dr. Stephen I. Katz: Maximizing the Value of NIH-funded Clinical Trials
In his latest letter, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Director, Stephen I. Katz, M.D., Ph.D., speaks on the new policies that the NIAMS and the NIH have implemented to enhance support for clinical research. Read the full letter on the NIAMS website.